Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
- Latest
- Trending
OSSGROW is India's first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country ...
Bihar Live, digital news and story platform bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.
